Basic Info

11010 Torreyana Road
San Diego, CA 92121
(858) 404-6600
  N/A
  N/A
Preferred contact:
  Harry G Stylli - President/CEO
Aurora Biosciences Corporation
Profile last edited on: 4/27/2012
Business Identifier: Instrumentation and biological reagents for ultra high-throughput drug screening
Public Profile:
In 2001, Aurora was acquired by Vertex Pharmaceuticals, itself an SBIR awardee in earlier days. Aurora Biosciences Corporation designs, develops and sells proprietary drug discovery systems, services and technologies to accelerate and enhance the discovery of new medicines by the pharmaceutical and biopharmaceutical industries. The Company develops screens, provides screening services, provides functional genomics services, licenses its proprietary technologies, and may ultimately realize royalty and milestone payments from the development and commercialization of drug candidates identified by its collaborators using the Company's technologies. It also recognizes revenue by developing and providing the UHTSS Platform to syndicate members. This platform is an ultra-high throughput screening system designed to allow assay miniaturization and overcome many of the limitations associated with the traditional drug discovery process.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :

      

Media coverage